|
Q |
Apr1 |
Acute phase response QTL 1 |
|
IEA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr12:24,805,022...52,308,831
|
|
Q |
Apr2 |
Acute phase response QTL 2 |
|
IEA |
|
RGD |
PMID:11817600 |
RGD:629561 |
|
|
Q |
Apr3 |
Acute phase response QTL 3 |
|
IEA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr10:15,776,754...60,776,754
|
|
Q |
Apr4 |
Acute phase response QTL 4 |
|
IEA |
|
RGD |
PMID:11817600 |
RGD:629561 |
|
|
Q |
Apr5 |
Acute phase response QTL 5 |
|
IEA |
|
RGD |
PMID:11817600 |
RGD:629561 |
|
|
Q |
Apr6 |
Acute phase response QTL 6 |
|
IEA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr14:1...41,415,516
|
|
Q |
Eae1 |
Experimental allergic encephalomyelitis QTL 1 |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr20:1...6,693,431
|
|
Q |
Eae10 |
Experimental allergic encephalomyelitis QTL 10 |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr14:17,906,850...18,558,619
|
|
Q |
Eae11 |
Experimental allergic encephalomyelitis QTL 11 |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr 4:1...40,471,598
|
|
Q |
Eae5 |
Experimental allergic encephalomyelitis QTL 5 |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
|
|
Q |
Eae6 |
Experimental allergic encephalomyelitis QTL 6 |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr 1:182,383,862...191,260,518
|
|
Q |
Eae7 |
Experimental allergic encephalomyelitis QTL 7 |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr 1:226,175,591...270,518,180
|
|
Q |
Eae8 |
Experimental allergic encephalomyelitis QTL 8 |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr19:41,720,609...49,971,820
|
|
Q |
Eae9 |
Experimental allergic encephalomyelitis QTL 9 |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr 6:84,490,437...129,490,437
|
|
Q |
Eaex |
Experimental allergic encephalomyelitis QTL x |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr 5:60,511,627...105,511,627
|
|
Q |
Eaey |
Experimental allergic encephalomyelitis QTL y |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
NCBI chr18:49,187,226...62,647,720
|
|
Q |
Eaez |
Experimental allergic encephalomyelitis QTL z |
|
IEA |
|
RGD |
PMID:10640775 |
RGD:61031 |
|
|
Q |
Pia1 |
Pristane induced arthritis QTL 1 |
|
IEA |
|
RGD |
PMID:9843218 |
RGD:61089 |
|
|
Q |
Pia11 |
Pristane induced arthritis QTL 11 |
|
IEA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr 1:93,903,998...191,260,518
|
|
Q |
Pia12 |
Pristane induced arthritis QTL 12 |
|
IEA |
|
RGD |
PMID:12111642 |
RGD:631225 |
|
|
Q |
Pia13 |
Pristane induced arthritis QTL 13 |
|
IEA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr14:33,424,686...102,238,540
|
|
Q |
Pia14 |
Pristane induced arthritis QTL 14 |
|
IEA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr16:62,414,464...75,736,480
|
|
Q |
Pia2 |
Pristane induced arthritis QTL 2 |
|
IEA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 4:22,288,453...63,245,191
|
|
Q |
Pia3 |
Pristane induced arthritis QTL 3 |
|
IEA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 6:100,704,576...136,029,228
|
|
Q |
Pia4 |
Pristane induced arthritis QTL 4 |
|
IEA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr12:18,749,469...36,488,809
|
|
Q |
Pia5 |
Pristane induced arthritis QTL 5 |
|
IEA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 4:63,245,026...129,846,354
|
|
Q |
Pia6 |
Pristane induced arthritis QTL 6 |
|
IEA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr14:18,915,454...42,433,608
|
|
|
Q |
Pia15 |
Pristane induced arthritis QTL 15 |
|
IEA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr10:24,662,123...73,695,339
|
|
Q |
Pia16 |
Pristane induced arthritis QTL 16 |
|
IEA |
|
RGD |
PMID:12817024 |
RGD:631850 |
|
|
Q |
Pia17 |
Pristane induced arthritis QTL 17 |
|
IEA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 7:132,099,939...137,014,596
|
|
Q |
Pia18 |
Pristane induced arthritis QTL 18 |
|
IEA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 8:84,192,326...132,782,436
|
|
Q |
Pia19 |
Pristane induced arthritis QTL 19 |
|
IEA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr18:76,272,104...81,806,852
|
|
Q |
Pia27 |
Pristane induced arthritis QTL 27 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia28 |
Pristane induced arthritis QTL 28 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia29 |
Pristane induced arthritis QTL 29 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr16:28,468,701...73,468,701
|
|
Q |
Pia30 |
Pristane induced arthritis QTL 30 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia31 |
Pristane induced arthritis QTL 31 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 1:12,820,494...57,820,494
|
|
Q |
Pia32 |
Pristane induced arthritis QTL 32 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 4:107,346,299...152,346,299
|
|
Q |
Pia33 |
Pristane induced arthritis QTL 33 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia34 |
Pristane induced arthritis QTL 34 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr X:96,916,163...141,916,163
|
|
Q |
Pia35 |
Pristane induced arthritis QTL 35 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 1:226,175,591...270,518,180
|
|
Q |
Pia36 |
Pristane induced arthritis QTL 36 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia37 |
Pristane induced arthritis QTL 37 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia38 |
Pristane induced arthritis QTL 38 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia39 |
Pristane induced arthritis QTL 39 |
|
IEA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr14:8,621,398...53,621,398
|
|